title: Diabetes: Cardiovascular safety of 'gliptin' therapy.
authors.forename: Gregory B
authors.initials: GB
authors.lastname: Lim
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives*; D000789:Angina, Unstable / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004151:Dipeptides / Q000627:therapeutic use*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D014498:Uracil / Q000031:analogs & derivatives*
chemical_list: D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D010880:Piperidines; D014498:Uracil; D000218:Adamantane
references.citation: N Engl J Med. 2013 Oct 3;369(14):1317-26
references.pmid: 23992601
references.citation: N Engl J Med. 2013 Oct 3;369(14):1327-35
references.pmid: 23992602